NUWE stock

Nuwellis Inc (NUWE) support and resistance · P/E 0.0, rev $8.7M

Nuwellis Inc (NUWE) is a medical devices company listed on US.

This page maps Nuwellis Inc (NUWE) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported NUWE revenue for 2024-12-31 was $8.7M. Net income was -$11.2M. Revenue was down 1.4% from 2023-12-31 to 2024-12-31. NUWE currently screens at market cap $47.8M and trailing P/E 0.0.

NUWE currently screens at market cap $47.8M and trailing P/E 0.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new NUWE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the NUWE quote page for the session range and the stock page for the full model.

Not investment advice.

Full NUWE analysis